NEW YORK (GenomeWeb News) — Sloning Biotechnology of Puchheim, Germany, on Monday said that Research and Innovation Japan will exclusively market and distribute its Slonomics gene-synthesis service and its Slonomax gene-mutant libraries in Japan.
 
“Sloning's products and services perfectly address the current demand in genomics research and protein engineering,” RIJ CEO Kiyohiko Hirasawa said in a statement.
 
Financial terms of the agreement were not released.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.